The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling. Intravenous glucose tolerance test.

The minimal model method is widely used to estimate glucose effectiveness (S(G)) and insulin sensitivity (S(I)) from intravenous glucose tolerance test (IVGTT) data. In the standard protocol (sIVGTT, 0.33 g/kg glucose bolus given at time 0), which allows the simultaneous assessment of beta-cell function, the precision of the individualized estimates often degrades and particularly so in the presence of reduced sampling schedules. Here, we investigated the use of a population approach, the iterative two-stage (ITS) approach, to analyze 16 sIVGTTs in healthy subjects and to obtain refined estimates of S(G) and S(I) in the population and in the individual subjects. The ITS is based on calculation of the population mean and standard deviation of the parameters at each iteration and then use of them as prior information for the individual analyses. Theoretically, the use of a prior in the ITS should improve the precision of the individual estimates. The customary approach (standard two stage, STS), where modeling is performed separately for each individual subject, does not take the population knowledge into account. We used both frequent (FSS, 30 samples) and (quasi-optimally) reduced (RSS, 14 samples) sampling schedules. For the FSS, STS gave estimates (mean +/- SD) for S(G) = 2.66 +/- 1.09 x 10(-2). min(-1) and S(I) = 6.46 +/- 6.99 10(-4). min(-1). microU(-1). ml, with an average precision of 51 (range 5-176) and 33% (3-91), respectively. RSS radically worsened the precision of both S(G) and S(I). However, RSS and ITS gave S(G) = 2.59 +/- 0.73 and S(I) = 6.06 +/- 7.28, with an average precision of 23 (12-42) and 27% (), respectively. In conclusion, population minimal modeling of sIVGTT data improves the precision of individual estimates of glucose effectiveness and insulin sensitivity, as the theory predicts, and, even with reduced sampling, the improvement is substantial.

[1]  Claudio Cobelli,et al.  Optimal Sampling Schedule Design May Reveal Inadequacy of Model Structure: a Case Study on the Minimal Model of Glucose Disappearance , 1988 .

[2]  R N Bergman,et al.  Modified protocols improve insulin sensitivity estimation using the minimal model. , 1987, The American journal of physiology.

[3]  Jerome J. Schentag,et al.  Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin , 1993, Antimicrobial Agents and Chemotherapy.

[4]  R N Bergman,et al.  Assessment of insulin sensitivity in vivo. , 1985, Endocrine reviews.

[5]  Claudio Cobelli,et al.  The hot IVGTT two-compartment minimal model: indexes  of glucose effectiveness and insulin sensitivity. , 1997, American journal of physiology. Endocrinology and metabolism.

[6]  M. Boehnke,et al.  A large sample of finnish diabetic sib-pairs reveals no evidence for a non-insulin-dependent diabetes mellitus susceptibility locus at 2qter. , 1998, The Journal of clinical investigation.

[7]  R. Bergman,et al.  Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators. , 1998, Annals of epidemiology.

[8]  G. W. Snedecor.  Statistical Methods , 1964 .

[9]  Giovanni Pacini,et al.  Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. , 1998, American journal of physiology. Endocrinology and metabolism.

[10]  C. Cobelli,et al.  A reduced sampling schedule for estimating the parameters of the glucose minimal model from a labeled IVGTT , 1991, IEEE Transactions on Biomedical Engineering.

[11]  modeling in physiology The hot IVGTT two-compartment minimal model : indexes of glucose effectiveness and insulin sensitivity , 1997 .

[12]  I. Hramiak,et al.  A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. , 1990, The Journal of clinical endocrinology and metabolism.

[13]  M. Rewers,et al.  Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. , 1999, Diabetes care.

[14]  Assessment of the global two-stage method to EC50 determination. , 1998, Journal of pharmacological and toxicological methods.

[15]  C Cobelli,et al.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. , 1998, Metabolism: clinical and experimental.

[16]  L B Sheiner,et al.  Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.

[17]  R. Bergman,et al.  Insulin Sensitivity and Abdominal Obesity in African-American, Hispanic, and Non-Hispanic White Men and Women: The Insulin Resistance and Atherosclerosis Study , 1996, Diabetes.

[18]  F. Collins,et al.  The W64R variant of the β3-adrenergic receptor is not associated with Type II diabetes or obesity in a large Finnish sample , 1999, Diabetologia.

[19]  Richard M Watanabe,et al.  A Comparison Between the Minimal Model and the Glucose Clamp in the Assessment of Insulin Sensitivity Across the Spectrum of Glucose Tolerance , 1994, Diabetes.

[20]  J F Boisvieux,et al.  Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. , 1984, Drug metabolism reviews.

[21]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[22]  Richard N Bergman,et al.  Reduced Sample Number for Calculation of Insulin Sensitivity and Glucose Effectiveness From the Minimal Model: Suitability for Use in Population Studies , 1993, Diabetes.

[23]  G. Tucker,et al.  Population-based modeling to demonstrate extrapancreatic effects of tolbutamide. , 1998, American journal of physiology. Endocrinology and metabolism.

[24]  A Forrest,et al.  An evaluation of optimal sampling strategy and adaptive study design , 1988, Clinical pharmacology and therapeutics.

[25]  Marie Davidian,et al.  Nonlinear Models for Repeated Measurement Data , 1995 .

[26]  A. De Gaetano,et al.  NONMEM improves group parameter estimation for the minimal model of glucose kinetics. , 1996, The American journal of physiology.

[27]  O. L. Davies,et al.  Statistical Methods. 6th Edition. , 1968 .

[28]  A Racine-Poon,et al.  A Bayesian approach to nonlinear random effects models. , 1985, Biometrics.

[29]  Ewart R. Carson,et al.  The mathematical modeling of metabolic and endocrine systems : model formulation, identification, and validation , 1983 .